Welcome : Guest

Pfenex, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Pfenex, Inc., which is principally a Clinical-Stage Biotechnology Company. Illustrated with 89 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-66263
Price: $3500
Company Type: Public
Pages: 91
Date: January 2017
Market Data Tables: 89

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Pfenex, Inc.'s Sales by Geographic Region Worldwide (2014-2015) in Percentage for USA, and Others......2
Biotechnology......4
Table 2: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......4
Table 3: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......5
Biotesting (Outsourced)......6
Table 4: Outsourced Biotesting Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Environment, Pharma and Others......6
Biotechnology Drugs......7
Table 5: Biotechnology Drugs by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Cell Therapy, Gene Therapy, Monoclonal Antibodies (MAB), Recombinant Hormones and Proteins, Vaccines, and Others......7
Biologics......8
Table 6: Biologics Market by Component Worldwide (2015) - Percentage Share Breakdown by Value for Insulin, Multiple Sclerosis, Oncology, Tumor Necrosis Factor, and Others......8
Table 7: No. of Biologics in Development by Therapeutic Area Worldwide (2015) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......9
Table 8: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......10
Table 9: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, and Chemicals......11
Table 10: Therapeutic Biologics Market by Type in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......12
Table 11: Biologics Therapeutic Classes Market by Category in China (2015) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......13
Table 12: Dermatology Biologics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......14
Biosimilars......15
Table 13: Biosimilars Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......15
Proteins......16
Table 14: Protein Market by Source Worldwide (2015) - Percentage Share Breakdown by Value for Animal, Fish, and Others......16
Table 15: Global Protein as Ingredient Market (2014) in Tons......17
Table 16: Protein Consumption by Category in Indonesia (2015) - Percentage Share Breakdown by Volume for Beef, Poultry and Others......18
Table 17: Proteins Market by Segment in China (2015) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibody (MAb), Nerve Growth Factor (NGF), and Somatropin......19
Table 18: Protein Analysis Market by End Use in the US (2015) - Percentage Share Breakdown by Value for Academic and Government, Biotech, Pharma and Contract Research Organizations (CROs), and Applied, Industrial and Others......20
Table 19: Protein Analysis Market by Product in the US (2015) - Percentage Share Breakdown by Value for Consumables/Services and Instrumentation......21
Animal Protein......22
Table 20: Animal Protein Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Chicken, Pork and Others......22
Table 21: Animal and Plant Protein Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Soy Protein Concentrate, Soy Protein Isolate, Textured Soy Protein, and Wheat......23
Human Protein......24
Table 22: Human Protein Consumption by Source Worldwide (2015) - Percentage Market Share Breakdown by Volume for Fish, Land Animals, and Others......24
Meat Protein......25
Table 23: Meat Protein Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Casein, Caseinates, Collagen, Egg Proteins, Gelatin, Milk Protein Concentrate, and Whey Proteins......25
Infectious Disease Drugs......26
Table 24: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......26
Table 25: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......27
Vaccines......28
Table 26: Vaccines Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Adult Prophylactic Vaccines (USD 8.5bn), Pediatric Vaccines (USD 16.7bn) and Others......28
Drugs......29
Table 27: Drugs Market by Region Worldwide (2015) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......29
Table 28: Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......30
Table 29: Spending on Drugs by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......31
Table 30: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......32
Table 31: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Brand, Generic and Other......33
Table 32: Drugs Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Biotechnology, Conventional and Other Unclassified......34
Table 33: Spending on Medicines by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Australia, Europe, Latin America, North America, and others......35
Table 34: Drug Market by Category in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......36
Table 35: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......37
Table 36: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......38
Table 37: Drugs Market by Category in Brazil (2015) - Percentage Share Breakdown by Volume for Generics and Others......39
Table 38: Drug Distribution Expenditure by Category in Canada (2015) - Percentage Share Breakdown by Value for Out of Pocket, Private Insurers and Public Payers......40
Table 39: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Medical Devices, Over-the-counter Drugs, Prescription Drugs, Traditional Chinese Medicine, and Others......41
Table 40: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Finished Drugs and Intermediate and Bulk Medicine......42
Table 41: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......43
Table 42: Finished Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Antihypertensive Drugs, Digestive System Drugs, Liver Drugs and Others......44
Table 43: Patent Medicines Sales by Drugs in China (2015) - Percentage Share Breakdown by Value for Cardio-Cerebrovascular Drugs, Digestive System Drugs, Drugs for Deoplastic Diseases, Gynecological Drugs, Musculoskeletal Drugs, Nervous System Drugs, Respiratory System Drugs, Urinary System Drugs and Others......45
Table 44: Drugs Market by Category in France (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......46
Table 45: Formulations Sales by Category in India (2015) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......47
Table 46: Drugs Market by Sector in Greece (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......48
Table 47: Ethical Drugs Revenues by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generic, Licensed and Unbranded Generic......49
Table 48: Drugs Market by Category in Italy (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......50
Table 49: Drugs Market by Category in Singapore (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......51
Table 50: Prescription Drugs Market in the US (2014) in US$ Million......52
Table 51: Critical Shortage Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectable, Orals, and Others......53
Table 52: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......54
Table 53: Critical Shortage Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Brand, Branded Generic, Generic, and Other Branded Generic......55
Table 54: Spending on Drugs by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Drugs and Traditional Drugs......56
Table 55: Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Non-specialty and Specialty......57
Table 56: Drugs Sales by Type in the US (2015) - Percentage Share Breakdown by Value for Cefdinir, Cephalexin, Cofactor and Others......58
Table 57: A-2 Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Generic Doxycycline, Generic Minocycline, Generic Tetracycline, and Others......59
Table 58: Spending on Medicines by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Pharmaceuticals and Traditional Pharmaceuticals......60
Table 59: Spending on Medicines by Product in the US (2015) - Percentage Share Breakdown by Value for Injectable, Oral and Other Forms......61
Table 60: Spending on Medicines by Segment in the US (2015) - Percentage Share Breakdown by Value for Biologics and Small-Molecules......62
Table 61: Spending on Medicines by Source in the US (2015) - Percentage Share Breakdown by Value for Non-Retail and Retail......63
Table 62: Spending on Medicines by Type in the US (2015) - Percentage Share Breakdown by Value for Branded Generics, Brands and Unbranded Generics......64
Drugs of Abuse Testing (DOA) Testing......65
Table 63: Drugs of Abuse Testing (DOA) Testing by Technology Worldwide (2015) - Percentage Market Share Breakdown by Value for Heterogeneous, Homogenous, and POC/Rapid......65
Epilepsy Drugs......66
Table 64: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......66
Biotechnology......67
Table 65: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......67
Table 66: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Other......68
Table 67: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......69
Outsourced Biotesting......70
Table 68: Market Shares of Leading Outsourced Biotesting Companies Worldwide (2015) - Percentage Share Breakdown by Value for Eurofins Scientific, SGS S.A. and Others......70
Colony-Stimulating Factor (GCSF)......71
Table 69: Market Shares of Leading Granulocyte Colony-Stimulating Factor (GCSF) Companies in China (2014) - Percentage Share Breakdown by Value for Amoytop Biotech Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Qilu Pharmaceutical Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., and Others......71
Biologics......72
Table 70: Market Shares of Leading Biologics/Vaccines Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Merial, Zoetis, Inc. and Others......72
Table 71: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Others......73
Table 72: Market Shares of Leading Biologic Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for AbbVie Inc., Amgen, Inc. and Pfizer, Inc., Johnson & Johnson, Roche Holding AG and Others......74
Biosimilars......75
Table 73: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015) - Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......75
Infectious Disease Drugs......76
Table 74: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......76
Vaccines......77
Table 75: Market Shares of Leading Vaccine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc (GSK), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......77
Diphtheria and Tetanus Vaccines......78
Table 76: Market Shares of Leading Diphtheria and Tetanus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Infanrix), and Others......78
Hepatitis A Vaccines......79
Table 77: Market Shares of Leading Hepatitis A Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Havrix), and Others......79
Hepatitis B (Recombinant) Vaccines......80
Table 78: Market Shares of Leading Hepatitis B (Recombinant) Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for Engerix (GlaxoSmithKline Plc), and Others......80
Hepatitis A and Typhoid Polysaccharide Vaccines......81
Table 79: Market Shares of Leading Hepatitis A and Typhoid Polysaccharide Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Hepatyrix), and Others......81
Human Papillomavirus Vaccines......82
Table 80: Market Shares of Leading Human Papillomavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Cervarix), and Others......82
Human Rotavirus Vaccines......83
Table 81: Market Shares of Leading Human Rotavirus Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Rotarix), and Others......83
Influenza Vaccines......84
Table 82: Market Shares of Leading Influenza Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Fluarix), and Others......84
Measles, Mumps and Rubella Vaccines......85
Table 83: Market Shares of Leading Measles, Mumps and Rubella Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Priorix), and Others......85
Tetanus Toxoid, reduced Diphthera Vaccines......86
Table 84: Market Shares of Leading Tetanus Toxoid, reduced Diphthera Vaccine Manufacturers in India (2014) - Percentage Breakdown by Value Sales for GlaxoSmithKline Plc (Boostrix), and Others......86
Typhoid Vaccines......87
Table 85: Market Shares of Leading Typhoid Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Typherix), and Others......87
Varilrix Vaccines......88
Table 86: Market Shares of Leading Varilrix Vaccine Manufacturers by Value Sales in India (2014) - Percentage Breakdown for GlaxoSmithKline Plc (Varilrix), and Others......88
Drugs......89
Table 87: Market Shares of Leading Drug Distributors Worldwide (2014) - Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......89
Table 88: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......90
Table 89: Market Shares of Leading Domestic Drugs Manufacturers in Vietnam (2015) - Percentage Share Breakdown by Volume for DHG Pharmaceutical JSC, Traphaco Joint Stock Company and Others......91